Viewing Study NCT04530994


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-27 @ 11:25 PM
Study NCT ID: NCT04530994
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2021-10-20
First Post: 2020-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)
Sponsor: Mirum Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module